Coura R N Diène

6PUBLICATIONS

34CO-AUTHORS

Molecular targetsCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesBiologically active molecules

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 16, 2026

Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent Cancers.

|Jan 30, 2026

Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer.

James S Scott, Laura Evans, Peter C Astles

|Oct 15, 2025

Focused Structure-Based Virtual Screening Identifies Novel Inhibitors of SOS1.

Silvia Bonomo, Floriane Gibault, Sharan K Bagal

|Jul 31, 2024

Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity.

James M Smith, Bernard Barlaam, David Beattie

|Jul 30, 2024

Structural and Physicochemical Features of Oral PROTACs.

Markus Schade, James S Scott, Thomas G Hayhow

|Jul 11, 2024

Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer.

Sharan K Bagal, Peter C Astles, Coura Diène

Pageof 1

Frequent Collaborators

Sharan K Bagal

James S Scott

Doyle J Cassar

Andy Pike

Argyrides Argyrou

Charlene Fallan

Jason G Kettle

Elisabetta Chiarparin

2 joint publications

Gavin W Collie

2 joint publications

Thomas G Hayhow

Frequent Collaborators

Sharan K Bagal

James S Scott

Doyle J Cassar

Andy Pike